Gastric acid-suppressive agents and risk of Clostridium difficile-associated disease

JAMA. 2006 Jun 14;295(22):2599-600; author reply 2600-1. doi: 10.1001/jama.295.22.2599-b.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Anti-Bacterial Agents
  • Clostridioides difficile*
  • Community-Acquired Infections / epidemiology
  • Comorbidity
  • Enterocolitis, Pseudomembranous / diagnosis
  • Enterocolitis, Pseudomembranous / epidemiology*
  • Gastrointestinal Agents / adverse effects*
  • Histamine H2 Antagonists / adverse effects
  • Humans
  • Proton Pump Inhibitors
  • Risk

Substances

  • Anti-Bacterial Agents
  • Gastrointestinal Agents
  • Histamine H2 Antagonists
  • Proton Pump Inhibitors